CDKN2A and meningioma: Other recently identified mutations are linked to a phosphatase tensin homolog on chromosome 10 (PTEN), as well as cyclin kinases CDKN2A/CDKN2B, main tumor suppressor genes predominantly implicated in meningioma progression [13,14,15].